You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 348 TIL engineered with membrane-bound IL15 (cytoTIL15™) are enriched for tumor-associated antigen reactivity and demonstrate pharmacologically tunable expansion and persistence in the presence of TAA

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Cellular Therapies
348 TIL engineered with membrane-bound IL15 (cytoTIL15™) are enriched for tumor-associated antigen reactivity and demonstrate pharmacologically tunable expansion and persistence in the presence of TAA

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023268018
Dec 20237109
Jan 20242602
Feb 20244201
Mar 20246207
Apr 20249807
May 20248808
Jun 20247608
Jul 20247705
Aug 20242803
Sep 20245205
Oct 20243209
Nov 20243809
Dec 20242406
Jan 20255804
Feb 20251405
Mar 2025003
Apr 2025104
May 2025009
Jun 2025102
Total10560124